ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Pruritus
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Food Hypersensitivity

Eczema trials near New York, NY, USA:

Locations recently updated

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...

Enrolling
Eczema, Atopic
Atopic Dermatitis
Drug: PF-08049820
Drug: Placebo

Phase 2

Pfizer
Pfizer

The Bronx, New York, United States and 19 other locations

The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...

Invitation-only
Atopic Dermatitis Eczema
Eczema
Drug: IMG-007

Phase 2

Inmagene

New York, New York, United States and 22 other locations

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Enrolling
Atopic Dermatitis Eczema
Eczema
Drug: Placebo
Drug: IMG-007

Phase 2

Inmagene

New York, New York, United States and 39 other locations

The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics of ATTO-1310 in healthy adults, patients with atopic derm...

Active, not recruiting
Atopic Eczema
Chronic Pruritus
Drug: ATTO-1310 Placebo
Drug: ATTO-1310

Phase 1

Attovia Therapeutics Inc

New York, New York, United States and 16 other locations

the treatment of adults with moderate to severe Atopic Dermatitis (Eczema). OpSCF will be compared to a placebo.OpSCF or placebo will be adm...

Active, not recruiting
Atopic Dermatitis
Biological: Placebo
Biological: OpSCF

Phase 2

Opsidio

Kew Gardens, New York, United States of America and 21 other locations

This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

Enrolling
Eczema Atopic Dermatitis
Eczema, Atopic
Drug: Camoteskimab
Drug: Placebo

Phase 2

Apollo Therapeutics

New York, New York, United States and 84 other locations

This study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe atopic dermatitis.

Active, not recruiting
Atoptic Dermatitis
Drug: EVO756
Drug: Placebo control

Phase 2

Evommune

East Syracuse, New York, United States and 26 other locations

Locations recently updated

This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to a...

Enrolling
Eczema
Atopic Dermatitis (AD)
Drug: Placebo
Biological: ARQ-234

Phase 1

Arcutis Biotherapeutics
Arcutis Biotherapeutics

Fair Lawn, New Jersey, United States and 1 other location

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 2...

Active, not recruiting
Atopic Dermatitis
Drug: Vehicle Cream
Drug: Tapinarof cream, 1%

Phase 3

Organon
Organon

New York, New York, United States and 47 other locations

The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to \<18...

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

East Windsor, New Jersey, United States of America and 88 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems